Engene Holdings INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
enGene Therapeutics Inc. announced its upcoming virtual Annual General Meeting on June 9, 2026, where shareholders will vote on director elections, auditor appointment, and review 2025 financial statements.
NASDAQ
enGene Holdings Inc. has announced its annual general meeting of shareholders to be held on June 10, 2025, in a virtual format, to vote on key proposals including the election of directors, approval of an employee stock purchase plan, and appointment of auditors.
NASDAQ
DEF 14A: enGene Holdings Inc. Announces Annual General Meeting and Proposes Incentive Equity Plan Amendment
enGene Holdings Inc. is set to hold its Annual General Meeting on May 15, 2024, featuring proposals including the election of directors and an amendment to the Incentive Equity Plan.